| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| Gene symbol | CLDN18 | Synonyms | SFTA5, SFTPJ | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q22.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | claudin 18 | ||||
| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| GTO ID | GTC1795 |
| Trial ID | NCT03302403 |
| Disease | B-Cell Leukemia | B-Cell Lymphoma | Pancreatic Carcinoma | Hepatocellular Carcinoma | Multiple Myeloma | Adenocarcinoma of Esophagogastric Junction |
| Altered gene | CD19|BCMA|GPC3|CLDN18 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA/CD19/CLDN18/GPC3 CAR-T cells |
| Recruitment status | Active, Not Recruiting |
| Title | Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors |
| Year | 2017 |
| Country | China |
| Company sponsor | First Affiliated Hospital of Wenzhou Medical University |
| Other ID(s) | CGZ001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||